Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Belgin Sarper Can and Asiye Durmaz Akyol
Objective: Chronic liver disease affects physical, psychological, social, economic problems and medical side effects in different levels. Because of these problems, the specific nature of a disease is best evaluated by a specific instrument. Specific instruments provide for nurses to capture the specific status of disease and make specific interventions to client and disease. Design: A cross-sectional and methodological design. Methods: The study data was collected from 170 patients with chronic liver disease. The validity of the instrument was examined with translation procedures, face validity, construct validity and concurrent validity. The reliability of instrument was examined with test-retest reliability and internal consistency. Results: It showed that factor analysis consisted of 3 levels which are Physical Health, Mental Health, and Social/Cognitive health. A negative relation was found between the mean score of CTP and the mean score of instrument (r=− 0.26, p<0.001). The test-retest reliability of instrument was found as 0.94 (ICC) p<0.01. The internal consistency Cronbach Alfa Coefficient of LDQOL 1.0 had good level and it was 0.80. Conclusion: At the end of study “LDQOL 1.0” was found that it is very reliable and a valid instrument for Turkish society in chronic liver disease.